Palo Alto, CA (PRWEB) October 08, 2012
Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced Dr. Glenn McGall as Senior Vice President of Technology.
“I am pleased to announce that Dr. Glenn McGall has joined us as our Senior Vice President, Technology,” said Dr. Wei Zhou, CEO and founder of Centrillion Biosciences." With his leadership and extensive expertise in the genomic technology and industry, we’ll be able to dramatically accelerate the development and commercialization of genomic technologies through our service and product offerings.”
Dr. McGall recently came from Affymetrix, where he was a vice president of research chemistry. He is a world renowned chemist with many years of experience in leading large scale genomic technology R&D. He has been instrumental in developing and commercializing high density microarray technology which fostered today’s rapid innovations in personalized medicine.
“I am very excited to join the Centrillion Biosciences team which includes several esteemed former colleagues” said Dr. Glenn McGall. “Centrillion has assembled a world class team. I am amazed to see in the short time since its founding, it has made tremendous break-throughs in technology development and impressed its customers with high quality genomic services.”
Dr. McGall earned a Ph.D. in organic chemistry from the University of Toronto and received his postdoctoral fellowship and training from MIT. He has been awarded 81 US patents and has numerous scientific publications.
About Centrillion Biosciences Inc.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise enables our customers to succeed in the most challenging genomic research projects.
Centrillion Biosciences, Inc.
2438 Embarcadero Way
Palo Alto, CA 94303